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Résumé de l'article 
« difficulties associated with out-patient management of drug abusers by general 
practitioners. A cross sectional survey of general practitioners with and without 
methadone patients in Switzerland. » Difficultés associées à la prise en charge des 
patients abusant de drogue par les médecins de premier recours. Une enquête postale 
chez les praticiens avec et sans patients sous méthadone en Suisse. 
A Pelet, J Besson, A Pécoud, B Favrat. BMC Family Practice 2005, 6: 51 
Contexte : En Suisse, les médecins de premier recours traitent la plupart des patients dépendants aux 
opiacés méthadone en tant que traitement de substitution. 
Méthode: Nous avons étudié les difficultés rencontrées dans la prise en charge des patients 
toxicodépendants en envoyant par poste un questionnaire d'enquête. Nous avons envoyé ce 
questionnaire à tous les médecins de premier recours de Suisse Romande prescrivant de la méthadone 
(556 médecins). Nous avons envoyé un autre questionnaire, plus court, à des médecins de premier 
recours du Canton de Vaud qui ne prescrivent pas de méthadone. 
Résultats: le taux de réponse global est de 63,3 %. La plus haute dose de méthadone donnée par les 
médecins de premier recours est de 120,4 mg/j (moyenne). Questionnés au sujet de l'aide qu'ils 
désireraient recevoir face à ces patients, les médecins de premier recours avec patients substitués par 
méthadone ont mentionné premièrement l'importance d'un meilleur remboursement des services 
prodigués. Les autres éléments demandés ont été une meilleure formation, de meilleures connaissances 
des pathologies psychiatriques et des groupes de discussion de cas cliniques. Les médecins sans 
patients sous méthadone refusent de traiter ces patients surtout pour des raisons émotionnelles et 
relationnelles. 
En conclusion : les médecins acceptant des patients sous méthadone rencontrent des difficultés 
relationnelles et émotionnelles. Ils désirent un meilleur remboursement pour les services prodigués. 
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Abstrac::t 
Background: ln Switzerland, general practitioners (GPs) manage most of the patients receiving 
methadone maintenance treatment {MMT). 
Methods: Using a cross-sectional postal survey of GPs who treat MMT patients and GPs who do 
not, we studied the difficulties encountered in the out-patient management of drug-addicted 
patients. We sent a questionnaire to every GP with MMT patients (556) in the French-speaking part 
of Switzerland ( 1,757,000 inhabitants). We sent another shorter questionnaire to primary care 
physicians without MMT patients living in the Swiss Canton of Vaud. 
Results: The response rate was 63.3%. The highest methadone dose given by GPs to MMT patients 
averaged 120.4 mg/day. When asked about help they would like to be given, GPs with MMT patients 
primarily mentioned the importance of receiving adequate fees for the care they provide. Secondly, 
they mentioned the importance of better training, better knowledge of psychiatrie pathologies, and 
discussion groups on practical cases. GPs without MMT patients refuse to treat these patients 
mostly for emotional and relational reasons. 
Conclusion: GPs encounter financial, relational and emotional difficulties with MMT patients. 
They desire better fees for services and better training. 
Background 
Methadone maintenance treatment (MMT) is extensively 
used for opiate addiction. Providing care in an office-
based practice is feasible [ 1,2] and produces outcomes 
comparable to those from specialist treatment (1,3-7]. 
Furthermore, it reduces the stigma associated with the 
diagnosis and treatment of substance abuse and increases 
the amount of attention paid to medical and psychiatrie 
conditions (3,4]. Easy geographical access to treatment 
encourages employment rehabilitation and retention in 
treatment [4]. However, GPs encounter specific difficul-
ties with this population: burnout, ladc of training, a neg-
ative attitude and a lack of motivation have been widely 
reported [3,8,9]. These difficulties prevent some GPs from 
accepting MMT patients. 
Furthermore, each country manages MMT in a different 
way: the UK encourages every general practitioner to pre-
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Table 1: Profile of office-based physicians with and without methadone substitution treatment 
PT (n = 352) PWT (n = 231) X2, p value 
Male 84.9% 82.7% x2 = o.4; P = o.563 
Practice in a town with > 10,000 inhabitants 60% 66.2% 
Practice in a town with < 10,000 inhabitants 40% 33.8% x2 = 2.3; p = o.136 
Works alone 57.9% 65.7% 
Works in a group practice (with other doctors) 42.1% 34.3% x2 = 3.5; P = 0.060 
Median no. of years in practice* (mean SD) 15 (14.8 ± 7.4) 17 (17 ± 8.6) z = -3.2; p = 0.001 
PT = General practitioners with patients receiving methadone substitution treatment 
PWT = General practitioners without patients receiving methadone substitution treatment 
*P value was calculated using the Mann-Whitney test; other P values were calculated using Fisher's exact test 
scribe methadone through national policies and guide-
lines; France usually reserves MMT for specialized centers 
and promotes the use of buprenorphine [ 10 ]; and the 
United States only recently began to allow GPs to pre-
scribe MMT. 
In Switzerland, most patients on MMT are treated by GPs, 
currently using the oral liquid form of methadone. 
Buprenorphine use is very rare and codeine is not encour-
aged. Only some specialized centers treat opiate abusers 
with injectable heroin. GPs have to register for every opi-
ate substitution with methadone to afford the double pre-
scription. 
The Swiss government encourages substitution treatment 
for drug-addicted individuals in the context of a hann-
reduction policy, but does not push GPs to accept these 
patients and has never distributed national guidelines 
broadly as has the UK. Generally, however, Swiss GPs are 
used to providing pharmacotherapies and other treat-
ments to drug users in our country. There is no shared care 
as in England, but Swiss GPs use a pragmatic approach, 
including meeting with social workers and pharmacists in 
charge of MMT patients. Groups of GPs involved with the 
drug-addicted have been created and receive support from 
the Federal Office of Public Health for continuous forma-
tion and clinical discussion. 
Specialized centers with psychiatrists, social workers, psy-
chologists and medical doctors offer multidisciplinary 
management for unstable patients. However, in Switzer-
land as elsewhere, there are not enough specialized cent-
ers for all drug addicts requiring treatment, and access is 
limited bygeographical barriers and the restricted number 
of treatment places that can be offered [ 11]. Furthermore, 
some geographical regions do not have specialized cent-
ers. 
Office-based treatment provides clear advantages for 
drug-abusing patients. However, primary care practition-
ers encounter specific difficulties with this patient popula-
tion. Bumout, lack of training, a negative attitude and a 
lack of motivation have been reported widely among the 
GP population [3,8,9]. These difficulties discourage and 
prevent primary care physicians from accepting drug 
abusers for substitution treatment. 
The ai ms of this study were to ( 1) to describe the specific 
difficulties with the MMT population encountered by pri-
mary care physicians and to identify why primary care 
physicians are reluctant to manage drug-abusing patients 
in Switzerland; and (2) to identify primary care physi-
cians' needs in terms of future management of drug-abus-
ing patients in the French-speaking part of Switzerland 
and to suggest solutions to help them. 
Methods 
We mailed a multiple-choice questionnaire designed to 
evaluate various aspects of the difficulties encountered in 
treating MMT patients: pharmacological issues (highest 
methadone dose), legal requirements, financial issues 
(how GPs get paid), emotional and psychiatrie aspects 
(including psychiatrie medication and referral to a psychi-
atrist ), relationships, multidisciplinary interactions ( e.g. 
with social workers or with pharmacists), motivation of 
primary care physicians, and specific management in the 
office setting. We collected the material to develop this 
questionnaire during semi-formal interviews with the 
staff at Saint-Martin (a specialized center for managing 
drug abusers). MedRoTox practitioners (a group of gen-
eral practitioners concemed with the problem of depend-
ency and supported by the Swiss Federal Office of Public 
Health) reviewed the questionnaire. During the calendar 
year 2000, we mailed it for anonymous completion to 
every primary care practitioner with MMT patients in the 
French-speaking part of Switzerland (556 physicians). 
This figure includes every GP prescribing methadone in 
this part of the country, which has a population of 
1,757,000. We sent the questionnaire again three months 
later to increase the response rate and received answers 
over the following three months. 
We sent another questionnaire to GPs without MMT 
patients to evaluate more specifically the factors that kept 
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Table 2: General practitioners who treat patients with methadone substitution (PT, n = 352) 
Would you accept new MMT patients? 
Actual number of patients on methadone treatment1 
How many patients would you like to have on MMT1 
Highest daily dose of methadone you ever prescribed: 
Yes: 23.9 % 
Mean (SD) 
6.2 (± 9.04) 
5.8 (± 6.9) 
120.4 mg(± 95.9) 
No: 73% (missing data: 3.1 %) 
Median 
4 
4 
100 mg (mode: 100 mg) 
PT = General practitioners with patients receiving methadone substitution treatment 
PWT = General practitioners without patients receivlng methadone substitution treatment 
MMT = Methadone maintenance treatment 
them from accepting these patients. We used the mailing 
list kept by the outpatient clinic at Lausanne University 
Hospital. These 365 GPs represent most of the primary 
care practitioners in the Swiss canton of Vaud. This ques-
tionnaire, also for anonymous completion, was also sent 
twice at an interval of three months. 
Bath questionnaires are available from the corresponding 
author. 
We used descriptive statistics and the chi-square test for 
comparison. We performed ail statistical analyses by SPSS 
software, version 11. 
Results 
Of the 556 targeted GPs with MMT patients (PT: practi-
tioners with MMTpatients), 63.3% (352) responded. We 
received replies from 231 ( 63%) of the targeted 3 65 pri-
mary care physicians without MMT patients (PWf: practi-
tioners without MMT patients). Table 1 shows the profiles 
ofboth groups of GPs. 
Bath populations (PT and PWf) were similar in terms of 
gender frequencies, practice location and the percentage 
who work in a group practice. The only statistically signif-
icant diff"erence was the mean number ofyears in medical 
practice (PT: 14.8 years, PWf: 17 years ). 
Table 2: Of the total PTs respondents, 73% would not 
accept more patients. The mean number (± SD) of MMT 
patients that a PTwould like to have (5.8 ± 6.9, median 4) 
was slightly less than the mean number that they actually 
treat (mean: 6.2 ± 9.04, median 4). Responding PTs 
reported an average highest daily methadone dose of 
120.4 mg/day (median = 100 mg/day, mode= 100 mg). 
The percentage of PWTs who had received requests for 
methadone treatment was 52%. Of the responding PWTs, 
42.9% had been involved in methadone treatment in the 
past but were no longer treating such patients. Of the 
PWfs, 88. 7% did not treat MMT patients because they 
refused to accept them into their practice. 
Table 3 shows the improvements reported by bath PTs 
and PWTs as necessary for improving MMT patient man-
agement. PTs mostly emphasized better reimbursement 
for related items of service. They also frequently men-
tioned better training (post-graduate or specialized psy-
chiatrie training) and more interaction with other 
professionals, including groups for discussing clinical 
cases. PWTs gave priority to having more centers and more 
specialized professionals for treating drug-addicted 
patients. 
Table 3: What could be done to fmprove the management of patients on methadone maintenance treatment (MMT)? 
Question: PT (n = 352) 
Better reimbursement for care 58.8% 
Better post-graduate training 50% 
Group discussion of clinical cases 50% 
Better knowledge of psychiatrie pathologies 46.6% 
More political commitment to drug-addicted patients 44.6% 
(more centers, more specialized professionals) 
More accessible specialized professionals 42% 
Better training at medical school 41.2% 
Better screening for drug addiction 18.2% 
by private practitioners 
Stronger political repression of illegal drugs 9.7% 
PT = General practitioners with patients on methadone substitution treatment 
PWT = General practitioners without patients on methadone substitution treatment 
PWT (n = 231) x2 p 
Question not asked 
31.2% 
22.9% 
21.2% 
64.1% 
37.2% 
19% 
16.5% 
19.5% 
56.9 <0.001 
42.8 <0.001 
38.7 < 0.001 
21.2 <0.001 
1.3 0.262 
6.0 0.014 
0.3 0.656 
11.5 0.001 
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Table 4: Questions about reimbursement and training for general practitioners who treat patients with methadone substitution (PT: n 
= 352) 
Question 
Do you have problems getting medical care reimbursed? 
How did you learn about MMT 
Would you like to participate in addiction-related training for doctors! 
learning through their own practice? 
post-graduate training? 
self-taught? (books or scientific articles) 
during your internship! 
yes 
Would you like to participate in workshops with physicians and others professionals involved in the field? 
56.7% 
76.1% 
58% 
49.7% 
15.6% 
65.3% 
50% 
PT = General practitioners with patients receiving methadone substitution treatment 
MMT = Methadone maintenance treatment 
Of the PT group, 56% of physicians reported difficulties 
with medical care reimbursement (table 4 ). Also, a total of 
76.1% had learned about MMT through their own prac-
tices rather than receiving formai training. Most Pfs are 
interested in investing time in further training. 
Table 5 shows reasons why PWfs refuse MMT patients. 
PWfs rated non-compliant patients as the biggest obstacle 
to management {59.7%) and preferred patients to be 
managed by a specialized center {57.1%). The "titne-con-
suming" nature of treatment for drug-addicted patients 
was another major reason {54.5%) cited for not accepting 
the m. 
Discussion 
The disindination of the PWfs to treat MMT patients 
(88.7%) raises the question of how to change this atti-
tude, especially in light of the growing need for MMT 
(9,700 patients treated with methadone in 1991 and 
mrormanon sugges1s an area warrannng rurmer researcn, 
and we need better tools to identify, reach, teach and 
encourage these physicians. 
The highest average daily dose ofmethadone {120.4 mg/ 
day, table 2) is not surprising in view of the recommenda-
tions in the literature: although daily doses of methadone 
may differ from one patient to another, some authors rec-
ommend daily doses between 60 and 100 mg/day [ 15-
19 ]. A UK postal survey addressed to GPs in 2001 identi-
fied a mean methadone dose of 36.9 mg [14]; although 
this information (the mean) differs from the information 
obtained in our study (highest methadone dose pre-
scribed ), our result is still higher than expected: generally, 
GPs are lmown to prescribe low doses of methadone, con-
trary to international recommendations [14,16]. How-
ever, Swiss GPs with MMTpatients seem to be more aware 
of these recommendations. We hypothesize that Pfs may 
have better formation and could be more concerned 
about methadone issues. 
Wh en asked how the management of MMT patients could 
be improved (table 3), Pfs first mentioned better reim-
bursement for services provided. In Switzerland, patients 
pay part of the costs of health care, with the mandatory 
health insurance system picking up the rest of the bill. In 
Weinrich and Stuart have demonstrated that professional 
and financial help are crucial for primary care practition-
ers in Scotland [2]. In the UK, financial rewards for gen-
eral practitioners helped them to accept and continue 
working with MMT patients (2, 14]. 
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Table S: Why do you refUse care for methadone treatment 
patients (general practitioners with no patients on methadone 
substitution treatment) (PWTs) (n = 231) 
Question 
Non-compliant patients 
A specialized center is better 
Time-consuming 
Lack of specialized training 
fear of being overwhelmed by drug-addicted patients 
feeling of powerlessness toward drug-addicted patients 
Difficulties with authorizations (too much paperwork) 
Lack of reimbursement for medical care 
Management with other professionals too difficult 
Difficulties with accompanying psychiatrie disorders 
Fear of manipulation by drug-addicted patients 
Lack of knowledge about illegal substances and medications 
Past experience of burnout with drug-addicted patients 
Fear of theft 
fear of problems with other, non-drug-addicted patients 
Fear of being threatened in the office 
fear of being considered "the drug-addict doctor" 
Existing centers are adequate for this population 
yes 
59.7% 
57.1% 
54.5% 
52.4% 
48.9% 
41.6% 
40.3% 
38.1% 
38.1% 
36.4% 
33.3% 
31.2% 
29.4% 
28.1% 
27.7% 
24.7% 
11.7% 
11.3% 
PWT = General practitioners without patients receiving methadone 
substitution treatment 
In contrast, PWfs suggest increasing the number of spe-
cialized centers and developing more accessible special-
ized professional help as the first steps towards improving 
MMT patient management (table 5). These suggestions 
are fully in keeping with their attitudes about not accept-
ing MMT patients. As the results showed, significantly 
more PTs than PWfs felt that better postgraduate training 
could improve the management of patients in MMT. 
aay or praa1ce m me psycma1nc service; 1ne omer l me 
University of Geneva) has 80 hours of teaching on alco-
hol- and drug-related problems. However, this formal 
training in addiction began only a few years ago. Each 
region also has its own training opportunities, depending 
on the local network. Although local discussion groups 
for clinical cases already exist, the high percentage of PTs 
http://www.biomedcentral.com/1471-2296/6/51 
who expressed a need for more training points to a current 
overall lack of training. 
Our study found that 76.1 % of PTs have leamed through 
their own daily practice how to manage methadone treat-
ment (table 4). This is another powerful illustration of the 
lack of training that doctors receive and makes an urgent 
case for the development ofbetter training opportunities 
for primary care practitioners who provide methadone 
treatment in Switzerland. 
Two concems mentioned with similar frequency by PTs 
were the need for more political support in the treatment 
of drug-addicted patients (provision of more centers, 
more specialized professionals) and the need for more 
accessible specialists (table 3). Interestingly, PTs are more 
interested in improving their own practices (through 
reimbursement of fees and training) than in developing 
other infrastructure for treating drug abusers. This finding 
illustrates the concentration of MMT patient treatment in 
the outpatient setting in Switzerland. 
The median number of patients managed by the PTs rep-
resented in the survey is fairly low (four per practitioner, 
table 2) but is comparable with a recent postal survey in 
England (3.58 patients with opiate substitution per pre-
scribing GP) [14]. However, when asked how many MMT 
patients they would like to treat, PTs responded with an 
even lower number. This finding underlines the limited 
capacity of a single physician to accept and treat MMT 
patients and the burden represented by these patients. In 
Switzerland, the primary care practitioners who accept 
patients for methadone treatment probably represent 
those doctors who are more trained and more interested 
more, 01aer pracuuoners were no1 as accusmmea w aeuv-
ering methadone. 
The response rate to the survey ( 63 .3% of PT and 630/o of 
PWf) is another limitation. Although it is a high rate for a 
nine-page questionnaire, the survey still represents the 
opinions of only some practitioners. Compared with the 
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literature, it was better than expected from a busy general 
practice [20]. Even if the retum rate was similar for PTs 
and PWfs, there could be a bias of greater interest in the 
subject or of greater persona! involvement. 
A final limitation is the fact that the questionnaire was not 
formally validated by inter-rater techniques. 
Conclusion 
Each country has specific needs and characteristics for 
drug management, depending on govemment policies 
and the existing health care network. Switzerland has a 
policy of decentralization and harm reduction based on a 
low-threshold approach and a broad access to MMT 
through GPs, a policy embroiled in major political and 
emotional controversies. "Shared care" only exists in spe-
cialized centers in the form ofmultidisciplinaryworkwith 
drug nurses, psychiatrists, social workers and GPs, but is 
reserved for more disruptive and unstable patients. In 
Switerzland, MMT prescribed outside specialized centers 
involves only a highly selected group of GPs trained in the 
addiction field. National policies, however, encourage 
GPs to work in multidisciplinary teams and to meet regu-
larly with social workers and other healthcare providers. 
If the intention is specifically to achieve a low-threshold 
approach through generalizing MMT prescription, we 
need to listen to suggestions made by the principal play-
ers, i.e. the general practitioners. PTs want reimbursement 
for their services and better training. The growing needs of 
drug-addicted patients, the spread of HIV and the greater 
emphasis on harm-reduction policies are surely powerful 
reasons for answering this plea and providing support to 
practitioners who accept MMT patients. 
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